111 related articles for article (PubMed ID: 30608915)
1. 68Ga-Prostate-Specific Membrane Antigen PET/CT: Incidental Finding of a Liposarcoma.
Militano V; Afaq A; Bomanji J
Clin Nucl Med; 2019 Feb; 44(2):e90-e92. PubMed ID: 30608915
[TBL] [Abstract][Full Text] [Related]
2. Schmorl's Node: Confusion Still Persists in 68Ga-Prostate-Specific Membrane Antigen Ligand PET/CT.
Sahoo MK; Ahlawat K; Yadav R; Gajendra S
Clin Nucl Med; 2018 Sep; 43(9):679-681. PubMed ID: 30036258
[TBL] [Abstract][Full Text] [Related]
3. Widespread Metastatic Prostate Carcinoma Shown by 68Ga-PSMA PET/CT.
Soydal C; Ozkan E; Yerlikaya H; Utkan G; Kucuk ON
Clin Nucl Med; 2016 Jun; 41(6):e294-5. PubMed ID: 26909710
[TBL] [Abstract][Full Text] [Related]
4. PSMA and FDG PET/CT Findings in Patient With Dedifferentiated Liposarcoma and Prostate Cancer Metastases.
Liao X; Sun H; Chen X; Fan Y; Zhang J
Clin Nucl Med; 2024 Jul; 49(7):652-654. PubMed ID: 38689438
[TBL] [Abstract][Full Text] [Related]
5. Gallium-68 Prostate-Specific Membrane Antigen PET Imaging.
Hofman MS; Iravani A
PET Clin; 2017 Apr; 12(2):219-234. PubMed ID: 28267455
[TBL] [Abstract][Full Text] [Related]
6. 68Ga-PSMA PET/CT in Giant Retroperitoneal Liposarcoma.
Inanir S; Kesim S; Ergelen R; Tınay İ; Türköz HK
Clin Nucl Med; 2019 Nov; 44(11):e612-e613. PubMed ID: 31524684
[TBL] [Abstract][Full Text] [Related]
7. Incidental Detection of Tracer Avidity in Liposarcoma on 68Ga-Labeled Prostate-Specific Membrane Antigen PET/CT.
Malik D; Mittal BR; Kumar R; Singh H; Bhattacharya A; Singh SK
Clin Nucl Med; 2018 Sep; 43(9):e334-e335. PubMed ID: 30080189
[TBL] [Abstract][Full Text] [Related]
8. 68Ga-Prostate-Specific Membrane Antigen-Avid Tubercular Lesions Mimicking Prostate Cancer Metastasis on Simultaneous Prostate-Specific Membrane Antigen PET/MRI.
Ahuja A; Taneja S; Thorat K; Jena A
Clin Nucl Med; 2017 Dec; 42(12):e509-e510. PubMed ID: 29036003
[TBL] [Abstract][Full Text] [Related]
9. Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer.
Sanli Y; Kuyumcu S; Sanli O; Buyukkaya F; İribaş A; Alcin G; Darendeliler E; Ozluk Y; Yildiz SO; Turkmen C
Ann Nucl Med; 2017 Nov; 31(9):709-717. PubMed ID: 28900854
[TBL] [Abstract][Full Text] [Related]
10. 68Ga-Prostate-Specific Membrane Antigen Uptake in a Malignant Pleural Effusion From Metastatic Prostate Cancer After Pleurodesis.
Sachpekidis C; Alberts I; Rominger A; Afshar-Oromieh A
Clin Nucl Med; 2019 Oct; 44(10):838-839. PubMed ID: 31283614
[TBL] [Abstract][Full Text] [Related]
11. Incidental Finding of Acute Lymphocytic Leukemia in a Prostate-Specific Membrane Antigen PET/CT.
Acksteiner C; Sounness B
Clin Nucl Med; 2019 Sep; 44(9):e529-e531. PubMed ID: 31306192
[TBL] [Abstract][Full Text] [Related]
12. Early Detection of Bilateral Testicular Metastases From Prostatic Adenocarcinoma Using 68Ga-PSMA Ligand PET/CT.
Weiberg D; Radner H; Derlin T; Thon WF
Clin Nucl Med; 2017 Jul; 42(7):563-564. PubMed ID: 28368893
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic sensitivity of Tc-99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga-68 PSMA PET/CT.
Lawal IO; Ankrah AO; Mokgoro NP; Vorster M; Maes A; Sathekge MM
Prostate; 2017 Aug; 77(11):1205-1212. PubMed ID: 28649735
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.
van Leeuwen PJ; Emmett L; Ho B; Delprado W; Ting F; Nguyen Q; Stricker PD
BJU Int; 2017 Feb; 119(2):209-215. PubMed ID: 27207581
[TBL] [Abstract][Full Text] [Related]
15. Oligometastases in prostate cancer : Metabolic response in follow-up PSMA-PET-CTs after hypofractionated IGRT.
Baumann R; Koncz M; Luetzen U; Krause F; Dunst J
Strahlenther Onkol; 2018 Apr; 194(4):318-324. PubMed ID: 29181556
[TBL] [Abstract][Full Text] [Related]
16. Image of the Month: Multifocal 68Ga Prostate-Specific Membrane Antigen Ligand Uptake in the Skeleton in a Man With Both Prostate Cancer and Multiple Myeloma.
Rauscher I; Maurer T; Steiger K; Schwaiger M; Eiber M
Clin Nucl Med; 2017 Jul; 42(7):547-548. PubMed ID: 28368889
[TBL] [Abstract][Full Text] [Related]
17. 68Ga Prostate-Specific Membrane Antigen Uptake in Renal Cell Cancer Lymph Node Metastases.
Einspieler I; Tauber R; Maurer T; Schwaiger M; Eiber M
Clin Nucl Med; 2016 May; 41(5):e261-2. PubMed ID: 26859205
[TBL] [Abstract][Full Text] [Related]
18. Patterns of relapse as determined by
Henkenberens C; Derlin T; Bengel FM; Ross TL; Wester HJ; Hueper K; Kuczyk MA; Christiansen H; von Klot CA
Strahlenther Onkol; 2018 Apr; 194(4):303-310. PubMed ID: 29134231
[TBL] [Abstract][Full Text] [Related]
19. The impact of [
Frenzel T; Tienken M; Abel M; Berliner C; Klutmann S; Beyersdorff D; Schwarz R; Krüll A; Bannas P
Strahlenther Onkol; 2018 Jul; 194(7):646-654. PubMed ID: 29572670
[TBL] [Abstract][Full Text] [Related]
20. Incidental Detection of Hepatocellular Carcinoma on 68Ga-Labeled Prostate-Specific Membrane Antigen PET/CT.
Patel D; Loh H; Le K; Stevanovic A; Mansberg R
Clin Nucl Med; 2017 Nov; 42(11):881-884. PubMed ID: 28902734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
